BlinkBio Overview
- Founded
- 2009

- Status
- Private
- Employees
- 8

- Latest Deal Type
- Later Stage VC
- Latest Deal Amount
- $525K

- Investors
- 4
BlinkBio General Information
Description
Developer of drug conjugate therapies designed to facilitate the treatment of cancer. The company's therapies use a targeting moiety to selectively deliver toxins inside cancer cells without harming the normal cells, enabling medical practitioners to treat cancer patients with improved safety and efficacy.
Contact Information
Website
Formerly Known As
Coferon, Inc.
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
- Alexandria Innovation Center
- 555 Heritage Drive, Suite 165
- Jupiter, FL 33458
- United States
+1 (800) 000-0000
BlinkBio Timeline
BlinkBio Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
7. Later Stage VC | 22-Jul-2019 | $525K | 000.00 | Completed | Generating Revenue | |
6. Later Stage VC | 19-Apr-2019 | 00.00 | 000.00 | Completed | Generating Revenue | |
5. Later Stage VC | 21-Jul-2017 | 000.00 | 000.00 | 000.00 | Completed | Generating Revenue |
4. Debt - General | 04-Mar-2016 | 000.00 | Completed | Generating Revenue | ||
3. Early Stage VC (Series B) | 16-Jul-2012 | 000.00 | 000.00 | 000.00 | Completed | Startup |
2. Early Stage VC (Series A2) | 13-May-2011 | $3M | $7.1M | 000.00 | Completed | Startup |
1. Early Stage VC (Series A1) | 05-Jan-2011 | $4.1M | $4.1M | 000.00 | Completed | Startup |
BlinkBio Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series A-2 | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00.00 | ||
Series A-1 | 0,000,000 | 00.000000 | 00 | 00 | 00 | 00.000 |
BlinkBio Executive Team (10)
BlinkBio Board Members (6)
Name | Representing | Role | Since |
---|---|---|---|
Colin Goddard Ph.D | Self | Chairman & Chief Executive Officer | 000 0000 |
Douglas Reed MD | Hatteras Venture Partners | Board Member | 000 0000 |
Michael Gargano | Argent Ventures | Board Member | 000 0000 |
Viren Mehta Ph.D | Self | Board Member | 000 0000 |
BlinkBio Signals
Growth Rate

0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile

-35.5%.
530%
Size Multiple

219x
Median
Size Multiple
219x, 100th %ile

0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialBlinkBio Investors (4)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Florida Institute for the Commercialization of Public Research | Not-For-Profit Venture Capital | Minority | 000 0000 | 000000 0 | |
Ascent Biomedical Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
Hatteras Venture Partners | Venture Capital | Minority | 000 0000 | 000000 0 | |
MedImmune Ventures | Corporate Venture Capital | Minority | 000 0000 | 000000 0 |